A Speedinvest portfolio company

Molecule

Sector
Health & Bio
Year Invested
2022
Connecting life science research to funding.

Molecule is creating collaborative ecosystems, where stakeholders in drug development can work together to expedite the process of bringing novel therapeutics to patients - connecting leading researchers to funding by turning intellectual property and its development into a liquid and easily investable asset.

Switzerland
Share
Links
LinkedIn
Related Companies
hi.health

Convenient and safe access to private health insurance billing.

Sector
Health & Bio
Exits
AI & Infra
Year Invested
2019
IOMED

Better ICD-10 coding and big data insights for hospitals.

Sector
Health & Bio
AI & Infra
Year Invested
2018
Juli

Improving life for people with chronic conditions.

Sector
Health & Bio
Year Invested
2022
MiLaboratories

The leader in immunome data analysis software with flagship product MiXCR.

Sector
Deep Tech
Health & Bio
Year Invested
2022
Molecule

Connecting life science research to funding.

Sector
Health & Bio
Year Invested
2022
Mpiriq

MPIRIQ links everyday clinical data with medical research to turn routine patient care into insights that accelerate new therapies.

Sector
Health & Bio
Year Invested
2024
NeuroHarmonics

Building the future of non-invasive neuromodulation using focused ultrasound to modulate deep brain circuits safely.

Sector
Health & Bio
Year Invested
2025
Nilo Health

The mental well-being support for your entire workforce.

Sector
Health & Bio
Marketplaces & Consumer
Year Invested
2022